ROGER JEFFS
CIK 1231615 · Chief Executive Officer · last filed 2026-07-14
ROGER JEFFS is a Chief Executive Officer who has filed 375 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for LQDA, was dated Jul 14, 2026. Across all open-market trades the lifetime net is −$193.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $232.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$232.64M
6
375
-$193.91M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LQDA | Chief Executive Officer | 2,207,342 | $90.22 | $199.15M | -$32.44M | 39 | 2026-07-14 |
| AXSM | Director | 105,565 | $212.74 | $22.46M | -$15.63M | 31 | 2026-06-11 |
| ALBIREO PHARMA, INC. (ALBO) Delisted | Director | — | $44.15 | — | $0 | 6 | 2021-06-28 |
| Dova Pharmaceuticals Inc. (DOVA) Delisted | Director | 0 | — | — | $701.9K | 7 | 2019-11-12 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Director | 9,908 | $0.18 | $1.8K | $100.5K | 3 | 2018-09-07 |
| UTHR | President & Co-CEO | 20,486 | $538.84 | $11.04M | -$146.64M | 268 | 2016-03-15 |
Recent Filings
375 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-14 | LQDA | Mixed | −7,082 | -$2.52M | EDGAR |
| 2026-06-11 | AXSM | Notice (144) | −286 | -$71.2K | EDGAR |
| 2026-06-11 | AXSM | Sell (S) | −572 | -$141.7K | EDGAR |
| 2026-06-10 | AXSM | Notice (144) | −286 | -$70.4K | EDGAR |
| 2026-06-10 | AXSM | Exer (M) | +1,429 | $0 | EDGAR |
| 2026-06-09 | AXSM | Grant (A) | — | $0 | EDGAR |
| 2026-05-28 | LQDA | Sell (S) | −6,428 | -$399.7K | EDGAR |
| 2026-05-26 | LQDA | Sell (S) | −75,000 | -$4.58M | EDGAR |
| 2026-05-20 | LQDA | Notice (144) | −106,428 | -$6.38M | EDGAR |
| 2026-05-20 | LQDA | Sell (S) | −75,000 | -$4.42M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.